Emerging preclinical research suggests ARA-290 may support cardiovascular and renal tissue protection, reduce age-associated declines in heart function, and modulate neuroinflammation relevant to neurodegenerative processes
Serious risks, including kidney strain, liver issues, allergic reactions, and rare cases of Stevens-Johnson syndrome, are linked to high doses, counterfeit vials, and unsupervised administration
To demonstrate the efficacy of MBCT in the treatment of clinically diagnosed depression in TBI patients, Bedard et al
Ferroptosis has been implicated in a number of disorders such as neurodegenerative diseases (amyotrophic lateral sclerosis (ALS), Alzheimers disease (AD), Parkinsons disease (PD), and Huntingtons disease (HD), etc.), ischemia/reperfusion injury, and kidney degeneration